MET and prostate cancer: Research findings have suggested potential mechanisms by which c-Met promotes prostate cancer progression, including the Zeb-1 signaling pathway [16], MAPK signaling pathway [17], alterations in the EMT marker expression pathway [18], and activation of the stem cell-related Notch pathway [19].